tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
ANNX
Annexon Biosciences
RESEARCH TOOLSreports

Annexon Biosciences (ANNX) Stock News & Sentiment

1,400 Followers
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
Premium
Company Announcements
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
7d ago
ANNX
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
Premium
Ratings
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
8d ago
ANNX
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
Premium
Ratings
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
9d ago
ANNX
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
Premium
Ratings
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
20d ago
ANNX
ANNX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANNX Upcoming Earnings Report: What to Expect?
1M ago
ANNX
Annexon Biosciences Announces Planned Retirement of Board Chairman
Premium
Company Announcements
Annexon Biosciences Announces Planned Retirement of Board Chairman
2M ago
8K
ANNX
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
Premium
Company Announcements
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
3M ago
8K
ANNX
More ANNX News >

ANNX News on the Web

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Annexon Biosciences (ANNX) and VolitionRX (VNRX)
TipRanks News
Neutral
Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High?
Zacks
Neutral
Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), Ascendis Pharma (ASND)
TipRanks News
Bullish
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
TipRanks News
Bearish
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
TipRanks News
Bullish
Annexon files automatic mixed securities shelf
TipRanks News
Neutral
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
TipRanks News
Bullish
Annexon Highlights Path to Multiple First-in-Class Therapies and Strong Cash Position for 2026
Market Chameleon
Neutral

News Score - Last 7 Days

Neutral
ANNX
Sector Average
Media Buzz
This Week1 articles
Weekly Average4.5 articles
News Sentiment
This Week50%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ANNX’s Media Buzz Sentiment?
1 articles about ANNX were published this week. In an average week, 4.5 articles are published.
    What is ANNX’s weekly average amount of articles?
    In an average week, 4.5 articles about ANNX are published.
      What is ANNX’s News Sentiment?
      50% of articles about ANNX were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        NBIXNeurocrine
        ANGOAngioDynamics
        AORTArtivion
        ORGOOrganogenesis Holdings
        Showing the stocks with the most bullish news sentiment over the past week